Uridax-F Tablets provide an established, clinically unified dual-combination therapy carefully developed for the continuous management, long-term stabilization, and regression of symptomatic Benign Prostatic Hyperplasia (BPH). In progressive male urological health, an enlarged prostate creates a dual obstructive challenge: a dynamic component caused by the tension of smooth muscle fibers within the bladder outlet, and a structural component caused by the physical volume expansion of the prostate tissue itself. This advanced formulation combines two highly synergistic classes of medication within a single unit, addressing both the immediate mechanical tightening and the underlying hormonal triggers safely over an extended care routine.
The synchronized formulation operates dynamically across two distinct therapeutic fronts:
-
Tamsulosin Hydrochloride (0.4 mg SR): A highly selective antagonist of $\alpha_{1\text{A}}$ and $\alpha_{1\text{D}}$ adrenoreceptors concentrated within the prostate matrix and bladder neck. Presented in a sustained-release architecture, it smoothly blocks sympathetic adrenaline signals over 24 hours, relaxing local smooth muscle tone to rapidly clear urine hesitation and increase flow velocity without causing sharp blood pressure drops.
-
Finasteride (5 mg): A competitive and specific inhibitor of Type II 5-$\alpha$ reductase, the intracellular enzyme responsible for converting testosterone into the highly potent androgen, dihydrotestosterone (DHT), inside prostate cells. By dramatically dropping circulating and intraprostatic DHT levels, it arrests epithelial tissue overgrowth, inducing cell apoptosis and leading to a structural shrinkage of the prostate gland over months of steady tracking.
Key Benefits
-
Complete Dual-Action Attack: Simultaneously melts away localized muscular tension for quick relief while actively working to reduce physical prostate gland volume.
-
Sustained-Release Dynamic: Tamsulosin component releases evenly over a 24-hour cycle, preventing sudden medicinal tracking drops and stabilizing urinary performance.
-
Prevents Disease Progression: Helps lower the statistical long-term tracking risks of developing acute urinary retention (AUR) or requiring surgical interventions like TURP.
-
Calms Bladder Urgency: Effectively drops frequent nighttime bathroom runs and uncomfortable sudden urges, drastically improving male lifestyle tracking parameters.
-
Trusted Quality Control: Manufactured under strict pharmaceutical guidelines of DH, ensuring exact dosage uniformity and premium active core stability.
Directions for Use
-
Take exactly as directed by your urologist or primary care physician.
-
Uridax-F must strictly be taken orally once daily, approximately 30 minutes following the exact same meal every day (preferably immediately after dinner or your evening meal). Taking it post-meal establishes a highly stable absorption tracking baseline.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it, as doing so will destroy the sustained-release matrix and cause rapid medicine dumping.
-
Commitment to Long-Term Regimens: While the alpha-blocker provides quick relief within days, the structural benefits of Finasteride can take 3 to 6 months to manifest clearly on ultrasound tracking panels. Maintain complete daily consistency.
Safety & Precautions
-
Do not modify your dose or stop usage suddenly without explicit professional direction, as urinary obstruction symptoms or hormonal flaring paths can return sharply.
-
Strict Contraindication for Women & Pediatrics: This medication is indicated exclusively for adult male urological profiles. Women who are pregnant or planning a pregnancy must not handle crushed or broken Uridax-F tablets. Finasteride can be absorbed through the skin and can cause severe development abnormalities in the external genitalia of a male fetus.
-
Initial Dizziness Warning: Tamsulosin can occasionally cause mild orthostatic hypotension (a sudden drop in pressure when rising quickly from a sleeping layout), leading to temporary dizziness. Avoid driving or navigating high platforms if you experience these parameters during early titration.
-
Inform your specialist before initialization if you have an underlying history of severe liver impairment, advanced kidney vulnerabilities, or are tracking PSA (Prostate-Specific Antigen) blood markers. Finasteride naturally drops baseline PSA levels by approximately 50%; your specialist will adjust your laboratory tracking analysis accordingly.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and ambient environmental room moisture pools.
-
Keep the tablets safely stored inside their original protective blister packaging layout until the exact second of consumption to preserve the sustained-release core components.
